Dear colleagues,

it is a great pleasure for me to invite you to this first "one topic-two days meeting" of the ESCMID Study Group for Biofilms focused on biofilm-based healthcare-associated infections.
The recently acquired knowledge on the pivotal role played by biofilm-growing microorganisms in healthcare-related infections has given a new dynamic to the detection, prevention and treatment of these infections in patients admitted to both acute care hospitals and long-term care facilities.
The main target of this meeting will be to review the new findings in this field on the basis of the scientific contributions of leading scientists and to update participants on the most recent findings on the emerging multidrug-resistant biofilm-growing microorganisms. Thus, microbiologists, hygienists and infectious diseases clinicians will be updated on the state-of-art of biofilm-based infections, particularly those related to the implant of medical devices, to the occurrence of pressure ulcers, to the prosthetic, plastic and reconstructive surgery, as well as on the well-known greater antibiotic resistance of these infections.
After the organization of EUROBIOFILMS 2009, the unforgettable First European Congress on Microbial Biofilms, this will be a further occasion to welcome at the Santa Lucia Foundation Research Hospital all the "biofilm's lovers" for an exciting meeting that I will be pleased and honored to chair on behalf of the Study Group for Biofilms of the European Society of Clinical Microbiology and Infectious Diseases.
Welcome all of you in Rome !

Gianfranco Donelli

ESGB Executive Board

Thomas BJARNSHOLT, Chairperson, Copenhagen, Denmark
Tom COENYE, Vice-Chairperson, Ghent, Belgium
Christine IMBERT, Secretary, Poitiers, France
Craig WILLIAMS, Treasurer, Kilmarnock,United Kingdom
Veronika HOLA, Elected Member, Brno, Czech Republic
Antonio OLIVER, Elected Member, Palma de Mallorca, Spain
Niels HOIBY, Past ESGB Chairperson, Copenhagen, Denmark
Gianfranco DONELLI, Past ESGB Vice-Chairperson, Rome, Italy

Local Organizing Committee

Gianfranco DONELLI (Chairperson)
Maria Pia BALICE, Iolanda FRANCOLINI, Antonio IERNA,
Francesca LONGO, Angelo ROSSINI, Antonino SALVIA, Claudia VUOTTO.

Scientific Secretariat

Dr. Claudia VUOTTO
Microbial Biofilm Laboratory (LABIM)
IRCCS Fondazione Santa Lucia
Rome, Italy
Telephone: +39 06 51501307
E-mail: c.vuotto@hsantalucia.it

Organizing Secretariat

Via Don Sturzo, 9 - 00040 Monteporzio Catone, Rome, Italy
Dr. Cinzia TOSTI
E-mail: tosti.c@myeventsrl.it
Telephone: +39 06916502389
Fax: +39 0689281786
Skype: cinzia.tosti1610


How to reach the Meeting venue

The Research Hospital Fondazione Santa Lucia is located about 5 km from the centre of Rome (Piazza Venezia) and about 5 km from the "Grande Raccordo Anulare" (external ring road - Exit n° 24, Via Ardeatina). The main entrance of the hospital is on Via Ardeatina 306 , but there is also a second entrance 100 mt ahead, closer to the Congress Center, that is operating on Via Ardeatina 354 and offers large parking areas (open and indoor).

Public bus services

- Bus 218 from Piazza San Giovanni (terminus) to Divino Amore sanctuary (terminus). There is an intermediate stop just in front of the main entrance
  of the Santa Lucia Foundation (Via Ardeatina 306); ask to the bus driver.
- Bus 769 from Piazzale Ostiense (terminus) to Viale Londra where the last stop is at about 20 metres from the third entrance of the Foundation on vicolo dell'Annunziatella.
- Bus 764 or 767 from Piazzale dell'Agricoltura (terminus) to Viale Londra (terminus); there is also an intermediate stop just in front of the Laurentina station (Metro B).

Shuttle bus

Shuttle bus will be offered free of charge exclusively to the registered participants accomodated in the hotels booked through the Organizing Secretariat.
These guests will be picked-up by a private shuttle-bus in front of the main entrance of their hotels at 8:00-8:15 and will be bring back at the end of the meeting sessions, around 18:30.

Visualizzazione ingrandita della mappa

Instructions for invited speeches and oral presentations

For presentations scheduled in the morning, speakers are kindly requested to provide their files by 09:00 while for those scheduled in the afternoon, files have to be uploaded from 14:00 to 15:00. Early morning presentations of Friday 10th can be uploaded the day before by 18:00.
Invited speeches will last 25 minutes plus 5 minutes for discussion while for oral communications 15 minutes plus 5 minutes for discussion will be available.
Presentation technology
The lecture hall is equipped with a laptop and a projector. In order to save time, the use of personal laptops is strongly discouraged.
Presentation format
Presentations in MS-PowerPoint 2010 or earlier versions (*.ppt and *.pptx) with a screen ratio of 4:3 will be accepted. If you are using PowerPoint 2007 or older versions please do not forget to upload also your video files as they cannot be visible when merged into the presentation.

Instructions for poster presentations

Presenters are requested to stand by their poster during the presentation time (14:00 - 15:00) in the assigned day only.
• Max. poster measurements (vertical presentation):
- width 70 cm
- height 100 cm

• We suggest a poster layout containing the following sections:
- Introduction
- Methods
- Results
- Conclusions

• The title should be emphasized by the use of a bold type face, so to be easily readable at a distance of 2-3 meters.
• Handouts to promote the work are encouraged to be distributed to interested participants.
• The right position to affix each poster will be indicated by numbers glued on the walls of the Poster Area. Poster numbers can be found on the congress website http://www.myeventsrl.it/biofilms/ under "Scientific programme" from September 15, 2014. Material to affix the posters will be provided by the organizers.
• All poster have to be affixed by 12:30 of Thursday , October 9th and have to be left for the entire duration of the meeting.

Slide center

A rehearsal room and support of a qualified technician will be available for invited and selected speakers. To upload files, please follow the "Instruction for invited speeches and oral presentations".

Internet access

A free wifi connection is available in the venue by using the password of the Congress Center that will be provided to all participants.


Thursday, October 9

09:00 Welcome addresses
Luigi Amadio, Director-General, Fondazione Santa Lucia
Carlo Caltagirone, Scientific Director, Fondazione Santa Lucia
Antonino Salvia, Medical Director, Fondazione Santa Lucia
Gianfranco Donelli, Head, Microbial Biofilm Laboratory, Fondazione Santa Lucia

Session 1: Biofilm-based infections in acute and long-term care facilities

Chairpersons: Veronika Hola, Steven Percival

Invited lectures

09:30 Urinary catheter-related infections: the diversity in UTI biofilms
Veronika Hola (Czech Republic)

10:00 Wound biofilms: evidence, bioreactors and antimicrobial interventions
Steve Percival (United Kingdom)

10:30 Coffee break

Oral communications

OC 1 10:50 Detection and discrimination of biofilm populations using Locked Nucleic Acid - Fluorescence In Situ Hybridization (LNA-FISH)
Azevedo Andreia Sofia (Portugal)

OC 2 11:10 Complex, multi-species biofilms, formed within a in vitro model of the human colon
Grace S. Crowther (United Kingdom)

OC 3 11:30 Probiotic lactobacilli do not integrate into oral biofilm in situ
Ali Al-Ahmad (Germany)

OC 4 11:50 How diabetes modulates P. aeruginosa physiology and biofilm formation in chronic wounds
Kendra P. Rumbaugh (USA)

OC 5 12:10 Regulation of Clostridium difficile biofilms
Meera Unnikrishnan (United Kingdom)

OC 6 12:30 Effect of nicotine on cariogenic virulence of Streptococcus mutans
Li Mingyun (China)

12:50 Lunch

14:00 Poster discussion (1-26)

Session 2: Biofilm-based infections after surgery

Chairpersons: Lise Hanne Christensen, Andrej Trampuz

Invited lectures

15:00 On the history from beginning to the end of adverse reactions to dermal fillers used in cosmetic surgery
Lise Hanne Christensen (Denmark)

15:30 Biofilm-associated infections in prosthetic surgery
Andrej Trampuz (Germany)

16:00 Coffee break

Oral communications

OC 7 16:20 Prevention of implant associated infection by improved skin disinfection Sheila Patrick (United Kingdom)

OC 8 16:40 Biofim of endotracheal tubes from patients with pneumonia caused by methicillin resistant Staphylococcus aureus treated with linezolid: preliminary results
Laia Fernandez-Barat (Spain)

OC 9 17:00 Role of sonication in the diagnosis and pathogenesis of cardiac device infections
Alessandra Oliva (Italy)

OC 10 17:20 Belfast Surgical Site Microbiota Project
Alessandra Frau (United Kingdom)

Friday, October 10

Session 3: Antibiotic treatment and resistance of biofilm-growing microorganisms

Chairpersons: Maria Dolores Macià Romero, Craig Williams

Invited lectures

09:30 Antimicrobial resistance and treatment of biofilm-growing bacteria
Maria Dolores Macià Romero (Spain)

10:00 Fungal biofilm resistance
Craig Williams (United Kingdom)

10:30 Coffee break

Oral communications

OC 11 10:50 Beta-glucan: an useful marker for diagnosis of invasive fungal infections
Maurizio Sanguinetti (Italy)

OC 12 11:10 Ability of Staphylococcus epidermidis to induce Candida albicans biofilm tolerance to echinocandins
Sonia Kucharikova (Belgium)

OC 13 11:30 Nanocarrier delivery of Myriocin, a sphingolipid metabolism inhibitor with antifungal activity, into fungal biofilms
Elisa Borghi (Italy)

OC 14 11:50 Pseudomonas aeruginosa biofilm inhibition by Quorum Sensing inhibitors/antibiotics combination
Aurélie Furiga (France)

OC 15 12:10 Evidence of daptomycin induction of S. aureus viable but non-culturable state in in vitro biofilms
Sonia Pasquaroli (Italy)

OC 16 12:30 Tobramycin-loaded biopolymeric nanoparticles for bacterial biofilms management
Enea Di Domenico (Italy)

12:50 Lunch

14:00 Poster discussion (27-51)

Session 4: Anti-biofilm strategies

Chairpersons: Christine Imbert, Tom Coenye

Invited lectures

15:00 Novel therapeutic strategies to control fungal biofilms
Christine Imbert (France)

15:30 Innovative therapeutic approaches to control bacterial biofilms
Tom Coenye (Belgium)

16:00 Coffee break

Oral communications

OC 17 16:20 Bacteria on surfaces – engineering surface microstructures to control bacterial adhesion and biofilm growth
Benjamin Hatton (Canada)

OC 18 16:40 Effect of gallium on Acinetobacter baumannii biofilm
Paolo Visca (Italy)

OC 19 17:10 Biofilm control using bacteriophages and derived enzymes
Joana Azeredo (Portugal)

OC 20 17:30 A New Small Molecule Targeting Glucosyltransferase Inhibits the Cariogenic Pathogen Streptococcus mutans Biofilm
Li Yu-Quing (China)

OC 21 17:50 Development of a biosensor for the screening of innovative anti-biofilm drugs
Livia Leoni (Italy)

18:10 ESGB awards for the best three posters
(Tom Coenye, Christine Imbert, Craig Williams)

18:30 Meeting's closing

Poster Session 1: Thursday, October 9

P1 The Clp ATPase ClpK promotes survival of biofilms of nosocomial and food-borne pathogens subjected to heat shock
E.J. Boll* (Copenhagen, Denmark), L. P. Andersen, K.A. Krogfelt and C. Struve.

P2 Antagonist role of 5 GGDEF/EAL proteins in biofilm formation by Legionella pneumophila
S. Pécastaings* (Toulouse, France.), J. Allombert, P. Doublet, C. Roques, A. Vianney

P3 Evaluation of Pseudomonas aeruginosa biofilms on granite surfaces with silver nanoparticles coating
A.V. Gutiérrez* (Caracas, Venezuela), M. Fernández-Delgado, P. Suárez, V. Salazar, M. A. García-Amado, M. Contreras, L. Lozada, G. González

P4 Cell wall deficient bacteria in oral biofilm: Prevalence and association with systemic medical conditions and periodontitis
F. Germano* (Rome, Italy), D. Testi, P. Melone, C. Arcuri

P5 Biofilm formation and cell adhesion of Enteroaggregative E. coli without known aggregative adherence fimbriae
R. Jønsson* (Copenhagen, Denmark), C. Struve, B. H. Jensen and K. A. Krogfelt

P6 Biofilm in carotid artery plaque
L. Nistico* (Pittsburgh, USA), R. Kreft, T. Smith, K. Rayl, T. Spirk, B. Byers, L. Hiller, D. Lasorda

P7 Glucose modulates Candida parapsilosis biofilms
S. Silva* (Braga, Portugal), L. Pereira, B. Ribeiro, M. Henriques, J. Azeredo

P8 Detection of P. aeruginosa in biofilm-associated cystic fibrosis infection by newly developed PCR protocols
M. Amiri* (Ancona, Italy), A. Di Cesare, G. Mangiaterra, S. Pasquaroli, E. Manso, B. Citterio, F. Biavasco

P9 A novel multiplex PCR Assay for rapid identification of Propionibacterium acnes phylogroups
A. McDowell, E. Barnard, A.J. Lee* (Belfast, UK), A. Frau, G. McLorinan, N. Eames, S. Patrick

P10 Sequence based community analysis of polymicrobial infections
S.-M. Marten, A. Neidig, O. Armant, U. Obst, J. Overhage, A. Dötsch* (Eggenstein-Leopoldshafen, Germany)

P11 Evaluatıon of bıofılm productıon of Candıda specıes recovered from clınıcal specımens
T. Demir, F. M. Sezgin* (Kırsehir, Turkey), G. Aytaç Alagöz, B. Özdemir, S. Erdemli, N. Karaca, Z. Cingör

P12 Characterizing the biofilm phenotype in Staphylococcus spp. from central venous catheters using two in vitro models
M. Van Kerckhoven* (Antwerp, Belgium), A. Hotterbeekx, E. Lanckacker, P. Moons, C. Lammens, M. Kerstens, M. Ieven, P. Delputte, P. Jorens, S. Malhotra-Kumar, P. Cos, S.H. Goossens, L. Maes

P13 Pseudomonas aeruginosa and Staphylococcus aureus biofilm, adhesion and dispersion on lenses under ketorolac and bromfenac influence. In vitro study
M. Arcos* (Buenos Aires, Argentina), M. Santalucia, A. Farinati, M. Márques.

P14 Escherichia coli biofilm formation and antibiotic susceptibility on biomedical materials
L.C. Gomes* (Porto, Portugal), L.N. Silva, M. Simões, L.F. Melo, F.J. Mergulhão

P15 Presence of sasX gene and assessment of biofilm production by detection of icaA, icaD genes and congo red agar method in coagulase-negative staphylococci
D. Ocal* (Ankara, Turkey), I. Dolapci, I. Mumcuoglu, Z. Gencturk, A. Tekeli

P16 Biofilm and antibiotic therapy for bone and joint infections due to Staphylococcus aureus
C. Marquès* (Clermont-Ferrand, France), J. Tasse, V. Collin, C. Franceschi, S. Badel, A. Pracros, T. Bernardi, F. Laurent, S. Chatellier and C. Forestier

P17 Antibiofilmogram®, an assay to identify antibiotic(s) able to prevent biofilms formation in OAI
J. Tasse* (Saint-Beauzire, France), S. Badel-Berchoux, C. Provot, D.Croisier-Bertin, C. Franceschi, S. Chatellier, T. Bernardi, F.Laurent

P18 Antibiofilm efficacy of selected antibiotics for Staphylococcus aureus isolates from diabetic foot infections
C. Franceschi* (La Balme Les Grottes, France), V. Collin, A. Sotto, S. Badel, J.-P. Lavigne, C. Dunyach, T. Bernardi, and S. Chatellier

P19 The Prevalence of Wound Infections in a University Hospital during Two Years
E. Us* (Ankara, Turkey), H. Kutlu, D. Gerceker, C. Karahan

P20 Antibiofilmogram®, a potential tool to optimize antibiotic therapy against biofilm formation in cystic fibrosis patients
E. Olivares* (Saint Beauzire, France), S. Badel-Berchoux, C. Provot, T. Bernardi, F. Jehl

P21 Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung
A. Pompilio, V. Crocetta, S. De Nicola, E. Fiscarelli, G. Di Bonaventura* (Chieti, Italy)

P22 Comparison of antimicrobial resistance rates of Acinetobacter baumannii strains recovered from clinical and environmental sources by biofilm formation ability
F. M. Sezgin* (Kırsehir, Turkey), T. Demir, G. A. Alagöz, B. Özdemir, Z. Cingör

P23 Sequential treatment (aztreonam-tobramycin) of Pseudomonas aeruginosa biofilms vs single or combined treatments. Analysis of laboratory isogenic hypermutable and mucoid strains
M. D. Macià* (Palma de Mallorca, Spain), E. Rojo-Molinero, B. Moyà, J. L. Pérez, R. Cantón, A. Oliver

P24 Detection of a matrix disassembly phenomenon improving the antibiotic killing activity towards very mature S.pneumoniae (Sp) in vitro biofilms
Y. Diaz Iglesias, F. Van Bambeke, N. M. Vandevelde* (Brussels, Belgium)

P25 Virulence and resistance features of A. baumannii associated with biofilm-based urinary tract infections
C. Vuotto* (Rome, Italy), F. Grosso, F. Longo, M. Carvalho de Barros, L. Peixe, G. Donelli

P26 Correlation between antibiotic resistance and biofilm formation in Klebsiella pneumoniae clinical isolates
C. Vuotto* (Rome, Italy), F. Longo, G. Donelli, M. P. Balice, A. Salvia, P.E. Varaldo

Poster Session 2: Friday, October 10

P27 Eradication of Burkholderia cenocepacia biofilms by Atmospheric Pressure Non-Thermal Plasma (APNTP)
N. Alshraiedeh* (Belfast, UK), M. Alkawareek, S. Gorman, W. Graham, B. Gilmore

P28 Biofilm formation on titanium implants counteracted by grafting gallium and silver ions
B. Azzimonti* (Novara, Italy), A. Cochis, C. Della Valle, R. Chiesa, L. Rimondini

P29 Impact of a sustained drug delivery system containing antimicrobial agent on mature biofilm
C.P. Aires* (Ribeirão Preto, Brazil), A.C. Santos, O. Freitas, M.P.G. Peixoto, M.P. Ferreira

P30 A new approach on vancomycin activity potentiation using medical device related osteomyelitis therapy
M. Ekizoğlu* (Ankara, Turkey), E.Sarıgöl, S. Bozdağ-Pehlivan, M. Özalp, E. Bodur, Ö. Çağlar, B. Atilla, S. Çalış

P31 Carboxylated poly(L-lactide) microparticles as carriers for usnic acid: evaluation of release behaviour and activity against S. epidermidis
A. Martinelli, I. Francolini* (Rome, Italy), A. Bakry, L. D'Ilario, V. Taresco, A. Piozzi

P32 Cyclic di-AMP is critical for Streptococcus mutans oxidative stress response, cell wall homeostasis and extracellular polysaccharides production
Xingqun Cheng, Xuedong Zhou, Xin Xu, Xian Peng, Wenxiang Jia, Yu-Qing Li* (Chengdu, China)

P33 Differential gene expression of Staphylococcus aureus and Staphylococcus epidermidis in dual species biofilms
I. Vandecandelaere, F. Van Nieuwerburgh, D. Deforce, H. Nelis, T. Coenye* (Ghent, Belgium)

P34 In vitro activity of vancomycin in combination with the enzyme alginate lyase against biofilm-forming Enterococcus faecium
F. Bugli, C. Santarini, M. Cacaci, C. Martini, R. Torelli, F. Paroni Sterbini, B. Posteraro, M. Sanguinetti* (Rome, Italy)

P35 Inhibition of biofilm formation in Staphylococcus aureus by GATG glycodendrimers
C. Mayer* (Santiago, Spain), A. Muras, M. Romero, J. Correa, E. Fernandez-Megia, A. Otero

P36 A study on the potential of dietary phytochemicals to inhibit quorum sensing and on their cytotoxicity in a mouse lung fibroblast cell line
A. Borges* (Porto, Portugal), M. J. Saavedra, M. Simões

P37 Novel anti-biofilm activity of the sulfuric amino acid L-cysteine
M. Bou Zeidan* (Sassari, Italy), S. Zara

P38 Xaa-prolyl dipeptidyl aminopeptidase may play an important role in biofilm formation by Streptococcus mutans
A. De* (Camerino, Italy), E. Camaioni, D. Petrelli, G. Lupidi, L. A. Vitali

P39 Anti-adherent and anti-biofilm activity of Leonurus cardiaca L. herb – derived extract and ursolic acid in the context of Staphylococcal endocarditis
B. Micota* (Lodz, Poland), B. Sadowska, A. Podsedek, B. Rozalska

P40 Inhibitory effect of lactic acid bacteria against oral Streptococci biofilms
E. Ciandrini, R. Campana, A. Manti, S. Papa, W. Baffone* (Urbino, Italy)

P41 In vitro activity of lipopeptide biosurfactant AC7 and Farnesol on Candida albicans biofilm formation on silicone
C. Ceresa* (Novara, Italy), F. Tessarolo, I. Caola, D. Maniglio, G. Nollo, L. Fracchia

P42 The prevention of oral Candida biofilm by new natural foodstuff substances: interest of proanthocyanidins, ellagitannins and ellagic acid derivates of raspberry
L. Dutreix, D. Costa, C. Loiseau, C. Imbert* (Poitiers, France), M. Girardot

P43 Interest of lichen extracts and thamnolic acid to fight biofilms of Candida albicans
M. Girardot, M. Millot, C. Lagrange, L. Dutreix, L. Mambu, C. Imbert* (Poitiers, France)

P44 Antibiotics and plant polyphenols synergy against Staphylococcus aureus biofilm
M. Paszkiewicz* (Lodz, Poland), B. Rozalska, A. Podsedek, B. Sadowska

P45 New anti-infective molecules from marine bacteria against S. aureus and P. aeruginosa
R. Papa* (Rome, Italy), E. Parrilli, M. Tilotta, G. Vrenna, F. Sannino, M.L.Tutino, M. Artini, L. Selan

P46 Anti-biofilm activity of Pseudoalteromonas haloplanktis against Staphylococcus epidermidis: evidences of a signal molecule involvement
E. Parrilli* (Naples, Italy), R. Papa, S. Carillo, M. Tilotta, A. Casillo, F. Sannino, M. Artini, L. Selan, M.M. Corsaro, M.L. Tutino

P47 The anti-biofilm activity secreted by the Antarctic bacterium Pseudoalteromonas haloplanktis TAB23
F. Sannino* (Naples, Italy), E. Parrilli, R. Papa, M. Tilotta, M. Artini, L. Selan, M.L. Tutino

P48 Anti-quorum sensing and anti-biofilm forming activity of selected citrus essential oils
L. Senerovic* (Belgrade, Serbia), J. Nikodinovic-Runic, B. Vasiljevic, V. Arsic-Arsenijevic

P49 Secreted protein by Staphylococcus aureus controls Staphylococcus epidermidis biofilm
M. Tilotta* (Rome,Italy), R. Papa, A. Cellini, G.Vrenna, L. Selan, M.Artini

P50 Inhibition of spoilage and pathogenic bacteria by two bacteriocinogenic lactic acid bacteria
Z. Benmouna* (Oran Es-Senia, Algeria), F. Dalache, H. Zadi-Karam, N-E. Karam

P51 Effect of quorum quenching activity bacteria on biofilm formation by Streptococcus mutans
A. Muras* (Santiago de Compostela, Spain), C. Mayer, M. Ferrer, A.Mira, M. Romero, A. Otero


Deadline for Abstracts submission: May 30, 2014

Extended Abstracts Submission Deadline: June 5, 2014

Abstract Submission Deadline for Poster only: June 27, 2014

Abstracts must be submitted to the Scientific Secretariat (c.vuotto@hsantalucia.it) according to the instructions provided in the guidelines reported in the following.

Presenting authors will be informed about the acceptance of their abstracts as posters or oral communications within July 4, 2014.

Authors with accepted abstracts are entitled to pay the early registration fee no later than July 10, 2014, only if registered before June 20, 2014

ESGB Executive Board will select among all the submitted abstracts a max of 26 oral communications to be assigned to appropriate Sessions.

Posters (not exceeding 70 cm width and 100 cm height) will be displayed for the whole duration of the Meeting.

The ESGB Executive Board will award a prize of 250 Euro to each of the best three posters.

The award ceremony will take place at the end of the Meeting.


  1.   1. Occurrence of microbial biofilm - associated infections in healthcare facilities
  2.   2. Host-pathogen interactions in biofilm infections
  3.   3. Methods to detect biofilm-based infections
  4.   4. Biofilm-based infections in long - term care facilities
  5.   5. Biofilm-based infections in intensive care units
  6.   6. Medical device- associated infections
  7.   7. Dental implants and biofilm-related infections
  8.   8. Biofilm-based infections in plastic and reconstructive surgery
  9.   9. Biofilm-based infections in orthopaedic and prostetic surgery
  10. 10. Infected wounds, pressure ulcers and diabetic foot ulcers
  11. 11. Antibiotic resistance in biofilm-growing microorganisms
  12. 12. Innovative treatments to prevent and control biofilm-based microbial infections
  13. 13. Novel strategies to counteract mixed-species biofilms
  14. 14. Antibiotic and antifungal molecules with claimed anti-biofilm activity
  15. 15. Natural and synthetic antibiofilm compounds

Guidelines for preparation and submission of Abstracts

In order to standardize the layout of the Abstract Book, please follow carefully these guidelines.
Abstracts must be submitted in English as Word format, and must contain original material neither published nor presented elsewhere prior to September 30, 2014

Abstracts should be structured using the following sub-headings: Objectives, Methods, Results, Conclusion.

Times New Roman must be selected as font and single line spacing is to be used for the entire abstract that should not exceed an A5 page. Tables, charts and other graphics are not permitted. References, when strictly necessary, can be cited in the text.

The title should be short and informative, with a maximum length of two lines. It should be written in bold letters, with a font size of 12 pt.
The name(s) of the author(s) should be written in regular letters, with a font size of 10 pt and the presenting author should be underlined.

Type the name(s) of the institution(s), city and country, in normal letters with a font size of 8 pt. To refer authors to their affiliations, please use progressive numbers within parentheses instead of superscript numbers.

Leave a blank line with font size of 12 pt. between the address(es) and the body text, that must be written with a font size of 10 pt and should not be longer than maximum 250 words.

Do not use Greek letters and symbols. Instead of 'IFN- γ' use for example 'IFN-g' or 'IFN-gamma'. For the symbols ≤ or ≥ type instead <= or >=. For superscript use caret (^) e.g. 10^6 instead of 106.

Genus and species names should be italicised and written in full on first mention, then abbreviated on subsequent mention; Generic drug names: lower case (penicillin); Brand names: capitalised with trademark symbol (e.g. Rocephin®).

Authors should indicate in their email:
• the topic of the abstract(s) selected among those listed in the section "Abstracts"
• their preference for oral or poster presentation, or for poster only

After having submitted the abstract, presenting author will receive within 3 working days an email confirming the successful submission. Otherwise, authors are invited to contact the Scientific Secretariat.

Abstracts will be subject to a peer review by the ESGB Executive Board and Scientific Secretariat to decide about their acceptance as oral or poster presentation. If accepted, the presenting author must attend the congress and present it in person. Cancellation of selected oral presentations must be communicated to the Scientific Secretariat no later than August 30, 2014.
Full instructions concerning the preparation of posters and the presentation of oral contributions will be emailed only to the presenting authors.



Early Registration fee***

until June 20, 2014

Registration fee

until July 18, 2014

Late Registration fee

until September 15, 2014

ESCMID member

180 Euro

250 Euro

300 Euro


250 Euro

300 Euro

350 Euro

Young scientist* ESCMID member

100 Euro

150 Euro

200 Euro

Young scientist* non member

150 Euro

200 Euro

250 Euro


75 Euro

100 Euro

150 Euro

Daily registrant

100 Euro

150 Euro

200 Euro

* Young scientists, born in 1978 or later (copy of ID card/ passport obligatory)
** Students need to attach a copy of their student ID
*** Authors with accepted abstracts are entitled to pay the early registration fee no later than July 10, 2014, only if registered before June 20, 2014.

Meeting attendance grants for ESCMID young scientist members
ESCMID provides a large number of attendance grants for ESCMID young scientist members, born in 1978 or later. The grant covers the registration fee, but not travel or accommodation costs.

Please, apply before June 5, 2014 via the ESCMID website at www.escmid.org/calendar.

Applicants will be informed about the grant award by July 4, 2014.
The grant's non- winners with accepted abstract will be allowed to pay the early registration fee until July 10th, only if registered before June 20, 2014.

On-site registrations will be not accepted.
Registration fees include a bag containing the Final Program/Abstract Book, the Certificate of Attendance and other meeting documents, as well as vouchers for the coffee breaks and working lunches.

Methods of payment
You can proceed with the payment by bank transfer or credit card (AMEX, MasterCard, PayPal, PostePay, VISA) only after you have received the confirmation of your registration to the Meeting by the Organizing Secretariat.

Please note that:
On-site payments cannot be accepted

Payments by personal cheques cannot be accepted
All payments have to be in Euro (EUR)



A large number of rooms have been reserved in 3* and 4* hotels located in the surroundings of the Meeting Venue. For all guests booking their accommodation trought MYEVENT, hotel rates will include WI-FI connection and the shuttle bus service to and from the Meeting Venue.

For hotel booking, the payment is required in full with your reservation. Your booking will be confirmed upon receipt of your payment. Your room will be guaranteed for late arrival. Additional expenses such as mini-bar and telephone must be paid directly to the hotel when checking out.


Questions? The organizing secretariat will be pleased to help you!

Send us a message

Organizing Secretariat

Via Don Sturzo, 9 - 00040 Monteporzio Catone, Rome, Italy
Dr. Cinzia TOSTI
E-mail: tosti.c@myeventsrl.it
Telephone: +39 06916502389
Fax: +39 0689281786
Skype: cinzia.tosti1610